Skip to main content
SpringerLink
Log in

Behandeling van insomnia: medicatie en/of gedragstherapie?

  • Consult
  • Published:
Psychopraxis, jaargang 2007

Abstract

In de traditionele geneeskunde, de psychiatrie en bij de meeste patiënten heerst nog steeds het idee dat men slaapproblemen het meest efficiënt kan aanpakken door middel van slaapmedicatie. Artsen schrijven dan ook zeer frequent slaapmedicatie voor. Uit de gegevens van het Nationaal Instituut voor Statistiek blijkt dat in 2004 in België het slaapmiddel Normison op de tweede plaats stond van de meest voorgeschreven geneesmiddelen. In deze bijdrage worden de medicamenteuze en de gedragstherapeutische behandeling voor insomnia met elkaar vergeleken. De voor- en nadelen van beide behandelingen worden besproken. Tenslotte worden de voor- en nadelen behandeld van een gecombineerde aanpak en gaan we in op de vraag of de medicamenteuze aanpak een negatief effect heeft op latere gedragstherapeutische behandeling.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. Pallesen S ea (2003) Behavioral treatment of insomnia in older adults: An open clinical trial comparing two interventions. Behaviour research and therapy 41: 31-34

  2. Morin CM (2006) Combined therapeutics for insomnia: Should our first approach be behavioral or pharmacological? Sleep medicine 20: 1-6

  3. Harvey AG & Tang NK (2003) Cognitive behaviour therapy for primary insomnia: Can we rest yet? Sleep medicine review 7: 237-262

    Espie CA ea (2001) The clinical effectiveness of cognitive behaviour therapy for chronic insomnia: implementation and evaluation of a sleep clinic in general medical practice. Behaviour research and therapy 39: 45-60

  4. Harvey AG & Tang NK (2003) Cognitive behaviour therapy for primary insomnia: Can we rest yet? Sleep medicine review 7: 237-262

  5. Lader MH (1999) Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified? European neuropsychopharmacology 9: 399-405

  6. Espie CA ea (2001) The clinical effectiveness of cognitive behaviour therapy for chronic insomnia: implementation and evaluation of a sleep clinic in general medical practice. Behaviour research and therapy 39: 45-60

    Lader MH (1999) Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified? European neuropsychopharmacology 9: 399-405

    Morin CM ea (2002) Are changes in beliefs and attitudes about sleep related to sleep improvements in the treatment of insomnia? Behaviour research and therapy 40: 741-752

    Vallières A ea (2005) Sequential combinations of drug and cognitive behavioral therapy for chronic insomnia: An exploratory study. Behaviour research and therapy 43: 1611-1630

    Edinger JO & Wohlgemuth WK (1999) The significance and management of persistent primary insomnia: the past, present and future of behavioral insomnia therapies. Sleep medicine review 3: 101-118

  7. Lader MH (1999) Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified? European neuropsychopharmacology 9: 399-405

  8. Lader MH (1999) Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified? European neuropsychopharmacology 9: 399-405

  9. Morin CM (2006) Combined therapeutics for insomnia: Should our first approach be behavioral or pharmacological? Sleep medicine 20: 1-6

  10. Vallières A ea (2005) Sequential combinations of drug and cognitive behavioral therapy for chronic insomnia: An exploratory study. Behaviour research and therapy 43: 1611-1630

    Edinger JO & Wohlgemuth WK (1999) The significance and management of persistent primary insomnia: the past, present and future of behavioral insomnia therapies. Sleep medicine review 3: 101-118

    Perlis ML (2003) On the comparability of pharmacotherapy and behavior therapy for chronic insomnia. Commentary and implications. Journal of psychosomatic research 54: 51-59

    Edinger JO & Means MK (2005) Cognitive-behavioral therapy for primary insomnia. Clinical psychology review 25: 539- 558

  11. Edinger JO & Wohlgemuth WK (1999) The significance and management of persistent primary insomnia: the past, present and future of behavioral insomnia therapies. Sleep medicine review 3: 101-118

  12. Edinger JO & Wohlgemuth WK (1999) The significance and management of persistent primary insomnia: the past, present and future of behavioral insomnia therapies. Sleep medicine review 3: 101-118

  13. Morin CM (2006) Combined therapeutics for insomnia: Should our first approach be behavioral or pharmacological? Sleep medicine 20: 1-6

  14. Perlis ML (2003) On the comparability of pharmacotherapy and behavior therapy for chronic insomnia. Commentary and implications. Journal of psychosomatic research 54: 51-59

  15. 9 Perlis ML (2003) On the comparability of pharmacotherapy and behavior therapy for chronic insomnia. Commentary and implications. Journal of psychosomatic research 54: 51-59

    Edinger JO & Means MK (2005) Cognitive-behavioral therapy for primary insomnia. Clinical psychology review 25: 539- 558

  16. Edinger JO & Wohlgemuth WK (1999) The significance and management of persistent primary insomnia: the past, present and future of behavioral insomnia therapies. Sleep medicine review 3: 101-118

  17. Morin CM (2006) Combined therapeutics for insomnia: Should our first approach be behavioral or pharmacological? Sleep medicine 20: 1-6

    Morin CM ea (2002) Are changes in beliefs and attitudes about sleep related to sleep improvements in the treatment of insomnia? Behaviour research and therapy 40: 741-752

    Vallières A ea (2005) Sequential combinations of drug and cognitive behavioral therapy for chronic insomnia: An exploratory study. Behaviour research and therapy 43: 1611-1630

    Edinger JO & Means MK (2005) Cognitive-behavioral therapy for primary insomnia. Clinical psychology review 25: 539- 558

  18. Edinger JO & Wohlgemuth WK (1999) The significance and management of persistent primary insomnia: the past, present and future of behavioral insomnia therapies. Sleep medicine review 3: 101-118

  19. Lader MH (1999) Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified? European neuropsychopharmacology 9: 399-405

  20. Morin CM ea (2002) Are changes in beliefs and attitudes about sleep related to sleep improvements in the treatment of insomnia? Behaviour research and therapy 40: 741-752

    Edinger JO & Wohlgemuth WK (1999) The significance and management of persistent primary insomnia: the past, present and future of behavioral insomnia therapies. Sleep medicine review 3: 101-118

Author information

Authors and Affiliations

  1. www.bsl.nl/shop/psychopraktijk-1878-4844.html

    Annelore Roose

Authors
  1. Annelore Roose
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Annelore Roose.

Additional information

is studente 3de licentie psychologie aan de KULeuven.

Haar bijdrage is gebaseerd op een paper voor het examen Gedragstherapie aan de KULeuven, juni 2006. Het is een bewerking van het artikel ‘Gedragstherapeutische behandeling van insomnie in vergelijking met een medicamenteuze aanpak: het nemen van medicatie zorgt voor een verminderd effect van de gedragstherapeutische behandeling’, dat eerder verscheen in het Berichtenblad Vlaamse Vereniging Gedragstherapie 2006 (4): 9-15.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roose, A. Behandeling van insomnia: medicatie en/of gedragstherapie?. PSYC 9, 49–52 (2007). https://doi.org/10.1007/BF03072338

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03072338

Search

Navigation